Showing results (121-130 of 287) with videos related to

Sort By:
Pageof 29
Current Opinion in Oncology|February 3, 2017
Recent developments in the management of germ cell tumorsPavlos Msaouel, Mehmet A Bilen, Miao Zhang, et al.
Advances in Experimental Medicine and Biology|March 26, 2014
Inflammation in age-related macular degenerationEma Ozaki, Matthew Campbell, Anna-Sophia Kiang, et al.
RMD Open|August 30, 2024
Successful management of pre-existing psoriatic arthritis through targeting the IL-23/IL-17 axis in cancer patients receiving immune checkpoint inhibitor therapy: a case seriesYuanteng Jeff Li, Pavlos Msaouel, Matthew Campbell, et al.
Evolutionary Applications|June 18, 2024
Advances in salmonid genetics-Insights from Coastwide and beyondShawn R Narum, Matthew Campbell, Katharine Coykendall, et al.
Current Eye Research|December 16, 2006
Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier functionMatthew Campbell, Ross Collery, Alice McEvoy, et al.
International Journal of Health Policy and Management|December 18, 2015
Introducing New Priority Setting and Resource Allocation Processes in a Canadian Healthcare Organization: A Case Study Analysis Informed by Multiple Streams TheoryNeale Smith, Craig Mitton, Laura Dowling, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
The mitochondrial-targeted peptide therapeutic elamipretide improves cardiac and skeletal muscle function during aging without detectable changes in tissue epigenetic or transcriptomic ageWayne Mitchell, Gavin Pharaoh, Alexander Tyshkovskiy, et al.
Aging Cell|March 13, 2025
The Mitochondria-Targeted Peptide Therapeutic Elamipretide Improves Cardiac and Skeletal Muscle Function During Aging Without Detectable Changes in Tissue Epigenetic or Transcriptomic AgeWayne Mitchell, Gavin Pharaoh, Alexander Tyshkovskiy, et al.
Fluids and Barriers of the CNS|September 28, 2024
NX210c drug candidate peptide strengthens mouse and human blood-brain barriersChris Greene, Nicolas Rebergue, Gwen Fewell, et al.
Advances in Experimental Medicine and Biology|March 26, 2014
Current therapeutic strategies for P23H RHO-linked RPAnh T H Nguyen, Matthew Campbell, Anna-Sophia Kiang, et al.
Pageof 29